Aggressive Blood Pressure Lowering Is Dangerous: The J-Curve: Pro Side of the Argument
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Controversies in Hypertension 29H istorically, the possibility that reducing blood pressure (Bp) might have harmful effects has gone through 3 temporal steps. in the first half of the last century, it was a widespread belief that an elevated Bp provided the necessary hydraulic gradient to preserve organ perfusion in the face of an increase in systemic vascular resistance, the implication being that hypertension was a compensatory mechanism and no Bp-lowering intervention was justified. 13][4][5][6] the possibility that antihypertensive treatment might produce harm rather than benefit resurfaced in the late 70s and 80s, 7,8 however, due in particular to a report that in patients with a high cardiovascular risk the incidence of myocardial infarction was diminished by reducing diastolic Bp to 85 to 90 mm Hg but increased when a more pronounced reduction occurred. 8Despite its important limitations (small number of patients, few cardiac events, and retrospective nature of the observations), the report was widely referred to and revived the popularity that has since characterized the J-curve phenomenon, that is, the possible J-shaped rather than linear relationship of Bp reductions by treatment with incident cardiovascular events.the present article will argue in favor of this hypothesis.it will be acknowledged that at present this is not supported by undisputable evidence such as that provided by randomized trials.it will be emphasized, however, that the J-curve hypothesis is supported by common sense, physiological data, and results from large-scale observational studies, often derived from antihypertensive treatment trials on individuals at high or very high cardiovascular risk.this makes it not just a remote but a real possibility, which deserves to be addressed by future studies. 9its important implications for clinical practice should make investigation on the J-curve phenomenon a priority for cardiovascular medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Self-citationEffects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Staessen, J. A., Fagard, R., Thijs, L., Celis, H., Arabidze, G. G., Birkenhäger, W. H., Bulpitt, C. J., de Leeuw, P. W., Dollery, C. T., Fletcher, A. E., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05381-6 · Cited by 2,989
Cited by
Bundy, J. D., Li, C., Stuchlik, P., Bu, X., Kelly, T. N., Mills, K. T., He, H., Chen, J., Whelton, P. K., & He, J. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.1421 · Cited by 783
Vidal-Petiot, E., Ford, I., Greenlaw, N., Ferrari, R., Fox, K. M., Tardif, J.-C., Tendera, M., Tavazzi, L., Bhatt, D. L., & Steg, P. G. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31326-5 · Cited by 470
Böhm, M., Schumacher, H., Teo, K. K., Lonn, E. M., Mahfoud, F., Mann, J. F. E., Mancia, G., Redon, J., Schmieder, R. E., Sliwa, K., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30754-7 · Cited by 315
Self-citationBenetos, A., Labat, C., Rossignol, P., Fay, R., Rolland, Y., Valbusa, F., Salvi, P., Zamboni, M., Manckoundia, P., Hanon, O., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.8012 · Cited by 287
Metadata
- Authors
- Mancia, G., & Grassi, G.
- Venue
- Hypertension
- Published
- 2014-01
- Volume
- 63
- Issue
- 1
- Pages
- 29-36
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2023872059
- Cited by
- 118
- References
- 7
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Aggressive Blood Pressure Lowering Is Dangerous: The J-Curve: Pro Side of the Argument. https://app.cochat.ai/papers/10.1161/hypertensionaha.113.01922
- The paper
- Mancia, G., & Grassi, G. (2014). Aggressive Blood Pressure Lowering Is Dangerous: The J-Curve: Pro Side of the Argument. Hypertension. https://doi.org/10.1161/hypertensionaha.113.01922
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.